Fundraising Fox

Cocoon Biotech, Inc.

Boston, US · Founded 2013 · Delaware corporation · 1 known investors

Biotech

Founders & leadership

AT
Ailis Tweed-KentNamed on SEC filing

Investors · 1

iSelect FundSt. Louis · $250K – $2M

Reported raises · per SEC filings

Form D private placements

$7.8M disclosed across 5 rounds · 2014–2021

▶$385.2KraisedDec 2021 · 6 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Charles KoppelDirector
  • Mary ThistleDirector
  • Annalisa JenkinsDirector
  • Ailis Tweed-KentExecutive Officer, Director
Offering amount
$1000K
Amount sold
$385.2K
First sale
Aug 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$865.4KraisedOct 2020 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Mary ThistleDirector
  • Annalisa JenkinsDirector
  • Ailis Tweed-KentExecutive Officer, Director
Offering amount
$865.4K
Amount sold
$865.4K
First sale
Oct 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4.5MraisedNov 2019 · 32 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Grace ColonDirector
  • Ailis Tweed-KentExecutive Officer, Director
  • Mary ThistleDirector
  • Annalisa JenkinsDirector
Amount sold
$4.5M
Minimum investment
$5K
First sale
Feb 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.8MraisedOct 2015 · 18 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Ailis Tweed-KentExecutive Officer, Director
Offering amount
$2.5M
Amount sold
$1.8M
First sale
Oct 2015
Incorporated
Corporation, Delaware, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$200KraisedJun 2014 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Ailis Tweed-KentExecutive Officer, Director
Offering amount
$750K
Amount sold
$200K
Minimum investment
$1K
Proceeds to insiders
$12.5K
First sale
Jun 2014
Incorporated
Corporation, Delaware, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Cambridge Massachusetts based Cocoon Biotech is raising $4,495,285.00 in New Debt Financing. - intelligence360intelligence360.news · Nov 2019

Frequently asked questions

Who are Cocoon Biotech, Inc.'s investors?
Cocoon Biotech, Inc.'s investors include iSelect Fund.
How much funding has Cocoon Biotech, Inc. raised?
Cocoon Biotech, Inc. has disclosed $7.8M raised across 5 rounds.
Where is Cocoon Biotech, Inc. headquartered?
Cocoon Biotech, Inc. is headquartered in Boston, US.